Cargando…
Reply to: Magnesium sulphate intravenously reduces tachycardia side-effects of β(2)-agonists
Intravenous magnesium sulphate reduces β(2)-agonist induced tachycardia https://bit.ly/3pPnGKl
Autores principales: | Powell, Colin, Erumbala, Gokul, Anzar, Sabu, Tonbari, Amjad, Salem, Ramadan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584561/ https://www.ncbi.nlm.nih.gov/pubmed/36338258 http://dx.doi.org/10.1183/20734735.0024-2022 |
Ejemplares similares
-
Stating the obvious: intravenous magnesium sulphate should be the first parenteral bronchodilator in paediatric asthma exacerbations unresponsive to first-line therapy
por: Erumbala, Gokul, et al.
Publicado: (2021) -
Magnesium sulphate intravenously reduces tachycardia side-effects of β(2)-agonists
por: Sellers, William F.S., et al.
Publicado: (2022) -
THE INTRAVENOUS INJECTION OF MAGNESIUM SULPHATE FOR ANESTHESIA IN ANIMALS
por: Auer, J., et al.
Publicado: (1916) -
Eclampsia Treated with Intravenous Injection of Magnesium Sulphate Solution
por: Roy, S. K.
Publicado: (1941) -
Intravenous Magnesium Sulphate for Analgesia after Caesarean Section: A Systematic Review
por: McKeown, Andrew, et al.
Publicado: (2017)